Objavljeni radovi:
[1]
1. Brkic, M., Balusu, S., Van Wonterghem, E., Gorlé, N., Benilova, I., Kremer, A., Van Hove, I., Moons, L., De Strooper, B., Kanazir, S. and Libert, C., 2015. Amyloid β oligomers disrupt blood–CSF barrier integrity by activating matrix metalloproteinases. Journal of Neuroscience, 35(37), pp.12766-12778. M21a http://www.jneurosci.org/content/35/37/12766?utm_source=TrendMD&utm_medium=cpc&utm_campaign=JNeurosci_TrendMD_1
[2]
2. Steeland, S., Gorlé, N., Vandendriessche, C., Balusu, S., Brkic, M., Van Cauwenberghe, C., Van Imschoot, G., Van Wonterghem, E., De Rycke, R., Kremer, A. and Lippens, S., 2018. Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease. EMBO molecular medicine, 10(4), p.e8300. M21a http://embomolmed.embopress.org/content/10/4/e8300.abstract
[3]
3. Balusu, S., Van Wonterghem, E., De Rycke, R., Raemdonck, K., Stremersch, S., Gevaert, K., Brkic, M., Demeestere, D., Vanhooren, V., Hendrix, A. and Libert, C., 2016. Identification of a novel mechanism of blood–brain communication during peripheral inflammation via choroid plexus‐derived extracellular vesicles. EMBO molecular medicine, 8(10), pp.1162-1183. M21a http://embomolmed.embopress.org/content/8/10/1162.abstract
[4]
4. Brkic, M., Balusu, S., Libert, C. and Vandenbroucke, R.E., 2015. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators of inflammation, 2015: 620581. M22 https://www.hindawi.com/journals/mi/2015/620581/abs/
[5]
5. Balusu, S., Brkic, M., Libert, C. and Vandenbroucke, R.E., 2016. The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier. Neural regeneration research, Apr;11(4):534-7. M22 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870896/
